Table 2.

Comparison of AIMS65, GBS, and RS in different outcome variables

	AIMS65	GBS	RS	p value
Endoscopic intervention (n = 126)	1.77 ± 0.1	11 ± 0.4	6.4 ± 0.2
No endoscopic intervention (n = 183)	1.28 ± 0.08	9.1 ± 0.33	4.1 ± 0.17	<0.0001 vs. endoscopic intervention
Transfusion (n = 192)	1.8 ± 0.8	11.9 ± 0.2	5.7 ± 0.2
No transfusion (n = 117)	0.97 ± 0.1	6.5 ± 0.4	3.8 ± 0.2	<0.0001 vs. transfusion
Died in the acute episode (n = 29)	2.4 ± 0.2	13.7 ± 0.6	7.1 ± 0.3
Survived the acute episode (n = 280)	1.4 ± 0.06	9.5 ± 0.2	4.8 ± 0.1	<0.0001 vs. died
Died within 6 months (n = 32)	2.2 ± 0.2	11.7 ± 0.7	6.3 ± 0.3
Survived after 6 months (n = 241)	1.3 ± 0.07	9.3 ± 0.3	4.6 ± 0.15	<0.0001 vs. died
Rebleeding (n = 13)	1.85 ± 0.4	12.7 ± 0.7	6.8 ± 0.5
No rebleeding (n = 296)	1.5 ± 0.06**	9.8 ± 0.3	4.9 ± 0.1	<0.02 vs. rebleeding. **n.s. (p = 0.4)

GBS, Glasgow–Blatchford score; RS, Rockall score. Values are expressed as mean ± standard deviation.